Valero Energy has shed 8% in a week, reversing a significant slice of the May rally that just days ago had the stock at its most bullish options posture in a year.
The reversal is sharp and broad. VLO closed Tuesday at $241.45, down from $262.62 when the last note filed on May 20. The sector is moving with it: PBF has dropped 9.2% on the week, MPC is off 4.4%, PSX down 3.3%, and CVI has lost 8.3%. Valero is not alone, but it is absorbing the hit harder than the large-cap names — the same pattern flagged in the prior peer note, where VLO's moves tend to amplify sector direction.
Options positioning has shifted but not alarmed. The put/call ratio has climbed back to 0.73 from its 52-week low of 0.61 hit just last week, though it remains only modestly above its 20-day average of 0.71 — a z-score of 0.47. The aggressive call-buying that defined the mid-May setup has faded, replaced by a more neutral posture. This is worth watching: the PCR ran above 1.0 in mid-April when the stock was under pressure, and it has not revisited those defensive levels despite the current pullback. Options traders look cautious, not panicked.
Short interest tells a quiet story. Shorts amount to roughly 2.9% of the free float — low by any reasonable measure. The week-on-week change is a trivial 0.3%, and the 30-day trend is firmly in the opposite direction, with SI down nearly 14% over that period. Borrow remains almost free at 0.42% annualised, and availability is exceptionally loose at 3,583% — meaning the lending pool holds roughly 35 shares available for every one currently borrowed. There is no meaningful short-side pressure here, and the week's selloff is not a squeeze story in reverse.
The Street is broadly neutral but nudging targets higher. Mizuho raised its target to $289 from $222 this morning while keeping a Neutral rating — a notable lift of $67 that still implies the stock has room to recover from current levels. That follows a cluster of target raises in late April from TD Cowen ($255), Citigroup ($259), and Morgan Stanley ($222). The mean target across analysts is $256, roughly 6% above Wednesday's close, which suggests the consensus view is that the pullback has created modest value. The outlier is Wolfe Research, which downgraded to Underperform in late April with a $203 target — the only explicit bear on the tape in recent weeks. Bulls cite widening refining margins, a tightening RIN market, and tariff tailwinds on foreign feed. Bears point to high US utilisation rates, inventory builds, and weak ethanol margins. The PE has compressed to 9.7x over 30 days, and EV/EBITDA has pulled back to 6.5x — both multiples moving in the direction that value-oriented buyers have historically found interesting in this name.
Insider activity over the past 90 days has been modestly net positive at roughly $10.1m in net value, though the most recent disclosed trade was a $1.9m sale by SVP Eric Fisher on May 18. The surrounding activity on May 6 was routine director award-and-sell mechanics. The net position is not a meaningful signal in either direction.
The next confirmed earnings event is July 30. With short interest low, borrow loose, and options only mildly defensive, the stock's direction heading into that print will be shaped more by crack spread data and inventory reports than by any positioning extreme — what to watch is whether the PCR drifts back toward the mid-April defensive range as the summer driving season data begins to land.
See the live data behind this article on ORTEX.
Open VLO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
